Incorporating molecular tools into early-stage clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18215108.
- Also identified by DOI 10.1371/journal.pmed.0050021 and PMC identifier 2211557.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The author discusses the implications of a new phase I trial investigating the role of rapamycin in patients with glioblastoma.
Medical subject headings
- Antineoplastic Agents
- Brain Neoplasms
- Clinical Trials as Topic
- Drug Delivery Systems
- Glioblastoma
- Neoplasm Proteins
- Protein Kinase Inhibitors
- Protein-Tyrosine Kinases